Found: 30
Select item for more details and to access through your institution.
Prevalence, progression, and management of advanced chronic kidney disease in a cohort of people living with HIV.
- Published in:
- HIV Medicine, 2022, v. 23, n. 10, p. 1078, doi. 10.1111/hiv.13317
- By:
- Publication type:
- Article
The Lipid-Lowering Effect of Tenofovir/Emtricitabine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, n. 3, p. 403, doi. 10.1093/cid/civ296
- By:
- Publication type:
- Article
Nadir CD4 T Cell Count as Predictor and High CD4 T Cell Intrinsic Apoptosis as Final Mechanism of Poor CD4 T Cell Recovery in Virologically Suppressed HIV-Infected Patients: Clinical Implications.
- Published in:
- Clinical Infectious Diseases, 2010, v. 50, n. 9, p. 1300, doi. 10.1086/651689
- By:
- Publication type:
- Article
Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4 + T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 4, p. 2202, doi. 10.3390/ijms23042202
- By:
- Publication type:
- Article
Hypertension is a key feature of the metabolic syndrome in subjects aging with HIV.
- Published in:
- Current Hypertension Reports, 2016, v. 18, n. 6, p. 1, doi. 10.1007/s11906-016-0656-3
- By:
- Publication type:
- Article
Prospective Study to Assess Progression of Renal Markers after Interruption of Tenofovir due to Nephrotoxicity.
- Published in:
- BioMed Research International, 2016, v. 2016, p. 1, doi. 10.1155/2016/4380845
- By:
- Publication type:
- Article
Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Alternation of Antiretroviral Drug Regimens for HIV Infection.
- Published in:
- Annals of Internal Medicine, 2003, v. 139, n. 2, p. 81
- By:
- Publication type:
- Article
Identifying the needs of older people living with HIV (≥ 50 years old) from multiple centres over the world: a descriptive analysis.
- Published in:
- AIDS Research & Therapy, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12981-022-00488-7
- By:
- Publication type:
- Article
Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 10, p. 2358, doi. 10.1093/jac/dkt183
- By:
- Publication type:
- Article
Switching the third drug of antiretroviral therapy to maraviroc in aviraemic subjects: a pilot, prospective, randomized clinical trial.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 6, p. 1382, doi. 10.1093/jac/dks539
- By:
- Publication type:
- Article
Different Plasma Markers of Inflammation Are Influenced by Immune Recovery and cART Composition or Intensification in Treated HIV Infected Individuals.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0114142
- By:
- Publication type:
- Article
Classification Models for Neurocognitive Impairment in HIV Infection Based on Demographic and Clinical Variables.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0107625
- By:
- Publication type:
- Article
Randomised Study to Assess the Efficacy and Safety of Once-Daily Etravirine-Based Regimen as a Switching Strategy in HIV-Infected Patients Receiving a Protease Inhibitor–Containing Regimen. Etraswitch Study.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0084676
- By:
- Publication type:
- Article
Compromised Immunologic Recovery in Treatment-Experienced Patients with HIV Infection Receiving Both Tenofovir Disoproxil Fumarate and Didanosine in the TORO Studies.
- Published in:
- Clinical Infectious Diseases, 2005, v. 41, n. 6, p. 901, doi. 10.1086/432879
- By:
- Publication type:
- Article
Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery.
- Published in:
- Journal of Translational Medicine, 2015, v. 13, n. 1, p. 1, doi. 10.1186/s12967-015-0601-2
- By:
- Publication type:
- Article
Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome.
- Published in:
- Journal of Translational Medicine, 2012, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-68
- By:
- Publication type:
- Article
A Specific Mobile Health Application for Older HIV-Infected Patients: Usability and Patient's Satisfaction.
- Published in:
- Telemedicine & e-Health, 2021, v. 27, n. 4, p. 432, doi. 10.1089/tmj.2020.0098
- By:
- Publication type:
- Article
Assessing main death pathways in T lymphocytes from HIV infected individuals.
- Published in:
- Cytometry. Part A, 2013, v. 83A, n. 7, p. 648, doi. 10.1002/cyto.a.22299
- By:
- Publication type:
- Article
A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV.
- Published in:
- PLoS ONE, 2020, v. 15, n. 9, p. 1, doi. 10.1371/journal.pone.0238575
- By:
- Publication type:
- Article
Effects of integrase inhibitor-based antiretroviral therapy on brain outcomes according to time since acquisition of HIV-1 infection.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-90678-6
- By:
- Publication type:
- Article
In Vivo, Non-Invasive Characterization of Human Bone by Hybrid Broadband (600-1200 nm) Diffuse Optical and Correlation Spectroscopies.
- Published in:
- PLoS ONE, 2016, v. 11, n. 12, p. 1, doi. 10.1371/journal.pone.0168426
- By:
- Publication type:
- Article
Interruptions of antiretroviral therapy in human immunodeficiency virus infection: are they detrimental to neurocognitive functioning?
- Published in:
- Journal of NeuroVirology, 2010, v. 16, n. 3, p. 208, doi. 10.3109/13550281003767710
- By:
- Publication type:
- Article
High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2018, v. 73, n. 9, p. 2452, doi. 10.1093/jac/dky201
- By:
- Publication type:
- Article
High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individuals.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: changes in bone turnover markers and circulating sclerostin levels.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 7, p. 2104, doi. 10.1093/jac/dkv063
- By:
- Publication type:
- Article
Improvement in bone mineral density after switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: two-centre randomized pilot study (OsteoTDF study)
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Improvement in bone mineral density after switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: two-centre randomized pilot study (OsteoTDF study).
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 12, p. 3368, doi. 10.1093/jac/dku300
- By:
- Publication type:
- Article